🔎 Trials Near Me

Hem › Neuroendokrina tumörer › Ohio

Kliniska studier för Neuroendokrina tumörer i Ohio

14 studier för Neuroendokrina tumörer söker deltagare vid platser i Ohio.

Städer i Ohio

Officiell studietext (engelska)

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  • University Hospitals Cleveland Medical Center, Cleveland
  • The Ohio State University Comprehensive Cancer Center, Columbus
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT06943755

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

  • Investigative Site, Canton
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT06881992

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

  • Cincinnati Children's Hospital Medical Center, Cincinnati
RekryterarFas 1
24 Months – 18 Years · Alla kön · Uppdaterad 25 sep. 2026 · NCT06441331

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT06263088

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

  • University Hospitals Cleveland Medical Center, Cleveland
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT07087054

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

  • Research Facility, Columbus
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT07165132

Project: Every Child for Younger Patients With Cancer

  • Children's Hospital Medical Center of Akron, Akron
  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Rainbow Babies and Childrens Hospital, Cleveland
  • och 5 fler
RekryterarObservationsstudie
Upp till ålder 25 · Alla kön · Uppdaterad 25 aug. 2026 · NCT02402244

Integrated Cancer Repository for Cancer Research

  • Aultman Alliance Community Hospital, Alliance
  • Aultman Hospital, Canton
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 19 till 110 · Alla kön · Uppdaterad 29 juni 2026 · NCT02012699

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • The Ohio State University Wexner Medical Center, Columbus
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 27 maj 2026 · NCT03093116

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

  • UH Cleveland Medical Center, Cleveland
  • Ohio State University, Columbus
RekryterarFas 1/2
Ålder 18 till 90 · Alla kön · Uppdaterad 14 maj 2026 · NCT05636618

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

  • Research Facility, Columbus
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 30 mars 2026 · NCT05477576

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 11 dec. 2025 · NCT06943521

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Cincinnati
  • Massive Bio SYNERGY-AI site, Columbus
  • Massive Bio SYNERGY-AI site, Mayfield Heights
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

  • Case Comprehensive Cancer Center, Cleveland
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2025 · NCT06805825

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.